DEPDC5-related focal epilepsy encompasses a spectrum of autosomal dominant focal epilepsies caused by heterozygous pathogenic loss-of-function variants in DEPDC5, the gene encoding DEP domain-containing protein 5 on chromosome 22q12. DEPDC5 is a critical component of the GATOR1 complex, a negative regulator of mTORC1 (mechanistic target of rapamycin complex 1) signaling. Under normal conditions, GATOR1 suppresses mTORC1 activity when amino acid levels are insufficient; DEPDC5 loss-of-function removes this brake, producing constitutive mTORC1 hyperactivation, abnormal cellular growth, focal cortical dysplasia at the lesion site, and focal network hyperexcitability. DEPDC5 accounts for an estimated 10–37% of familial focal epilepsies, making it one of the most common genetic causes in this group.
The clinical spectrum ranges from Familial Focal Epilepsy with Variable Foci (FFEVF) — in which family members with the same variant manifest seizures from different lobes depending on individual somatic factors — to severe focal cortical dysplasia Type II driven by a DEPDC5 germline variant plus a somatic second-hit mutation at the cortical lesion. Many DEPDC5 patients are drug-resistant. mTOR inhibitors (everolimus, rapamycin) are an emerging precision therapy for DEPDC5 epilepsy, and a subset of patients with structural focal cortical dysplasia are candidates for surgical resection. DEPDC5 variants also carry elevated SUDEP risk, with animal models demonstrating cardiac and respiratory involvement during seizures via mTOR pathway effects in the brainstem.
The care technology platforms coordinating DEPDC5 management — seizure diary applications, presurgical evaluation portals, mTOR inhibitor therapy monitoring systems, nocturnal monitoring platforms, family cascade testing registries, and multidisciplinary epilepsy care coordination portals — are the digital infrastructure linking patients, epileptologists, neurosurgeons, geneticists, and families across a long and medically complex trajectory. This guide explains what must be monitored, why availability in DEPDC5 care platforms is a patient safety issue, and how to build a monitoring strategy calibrated to the real stakes of drug-resistant focal epilepsy management with SUDEP risk.
Why DEPDC5 Focal Epilepsy Care Tech Platforms Require Specialized Monitoring Attention
Seizure diary platforms are the primary data source for drug resistance documentation and mTOR therapy response assessment. DEPDC5 patients often trial multiple antiseizure drugs before establishing drug resistance (≥2 failed adequate trials), and documenting each trial, its response, and the reason for discontinuation is clinically essential for both care coordination and presurgical evaluation eligibility. Nocturnal focal seizures in DEPDC5 are particularly under-counted without seizure diary support and bed sensor integration. Seizure diary downtime during a period of drug transition or mTOR therapy initiation introduces gaps in the medication-response record that clinicians cannot reconstruct. Monitor seizure diary submission and synchronization endpoints at 5-minute intervals, 24/7, with sustained-failure alerting.
mTOR inhibitor therapy monitoring platforms carry direct pharmacological risk if unavailable. Everolimus and rapamycin used in DEPDC5 precision therapy require regular monitoring of blood sirolimus levels, complete blood counts, metabolic panels, infection surveillance, and wound healing assessment. Scheduling platforms and laboratory result delivery systems that become unavailable can delay dose adjustments in patients at risk for mTOR inhibitor toxicity or subtherapeutic levels. Monitor mTOR inhibitor therapy scheduling and lab result delivery endpoints at 3-minute intervals during daytime hours with 10-minute sustained-failure alerting.
Presurgical evaluation portals coordinate a time-sensitive, multi-modal diagnostic workup. Patients with DEPDC5 focal cortical dysplasia are potentially surgical candidates, but presurgical evaluation is a complex, sequenced process involving high-resolution MRI, FDG-PET, stereo-EEG (sEEG), and multidisciplinary surgical conference review. Coordination portal downtime can delay sEEG scheduling, MRI review uploads, or surgical conference preparation — setbacks that often translate to months of additional seizures in drug-resistant patients. Monitor presurgical evaluation portal endpoints at 3-minute intervals during business hours with alerting on 10-minute sustained failures.
Nocturnal monitoring platforms are the SUDEP prevention infrastructure. DEPDC5 patients with nocturnal seizures (nocturnal frontal lobe epilepsy is a common DEPDC5 phenotype) face heightened SUDEP risk, and nocturnal monitoring — bed-based movement and respiratory sensors feeding a monitoring platform — is a key clinical recommendation. A silent failure in the nocturnal monitoring alert pipeline means a nocturnal seizure could occur without any caregiver notification. Monitor nocturnal sensor data ingestion and alert generation endpoints at 1-minute intervals, 24/7, with immediate alerting. This is the highest-priority monitor on the platform.
Family cascade testing platforms support autosomal dominant risk management. DEPDC5 variants are autosomal dominant with variable expressivity — family members who carry the variant may have subclinical epilepsy or be completely asymptomatic. Family cascade testing platforms coordinating genetic test ordering, variant confirmation, and family counseling scheduling ensure at-risk relatives are identified before a first potentially life-threatening seizure. Monitor cascade testing portal and appointment booking endpoints at 5-minute intervals during business hours.
GATOR1-complex gene panel portals support diagnostic completeness. Co-mutations in NPRL2 and NPRL3 — the other two GATOR1 complex components — produce similar phenotypes, and compound heterozygous DEPDC5/NPRL2/NPRL3 families have more severe presentations. Family trio testing platforms that route genetic panel orders and deliver results to clinical and genetic counseling teams must remain available throughout the diagnostic process. Monitor genetic panel submission and result delivery endpoints at 5-minute intervals during business hours.
Multidisciplinary epilepsy care coordination portals integrate the DEPDC5 team across epileptology, neurosurgery, genetics, and nursing. DEPDC5 management involves complex cross-specialty coordination between outpatient epileptologists, presurgical evaluation teams, neurosurgeons, clinical geneticists, and case managers. Portal downtime during presurgical conference preparation, sEEG planning, or mTOR therapy initiation delays the coordinated action that distinguishes high-quality DEPDC5 care from fragmented management. Monitor care coordination portal endpoints at 3-minute intervals with alerting on 10-minute sustained failures.
What to Monitor on a DEPDC5 Focal Epilepsy Care Tech Platform
Nocturnal Monitoring — Seizure Alert and Respiratory Sensor Pipeline
Monitor the data ingestion endpoints receiving bed sensor movement and respiratory data, the seizure detection and classification pipeline, and the caregiver alert generation service. Check at 1-minute intervals, 24/7 — nocturnal seizures in DEPDC5 can occur at any hour, and a nocturnal monitoring pipeline failure is a direct SUDEP risk event. Alert immediately on any failure. This is the highest-priority monitor on the platform.
Seizure Diary Submission and Synchronization
Monitor the seizure diary entry submission endpoint, the synchronization API feeding clinical review dashboards, and the seizure frequency trend calculation service. Check at 5-minute intervals, 24/7. Alert after 15 minutes of sustained failure.
mTOR Inhibitor Therapy Scheduling and Lab Result Delivery
Monitor the therapy scheduling endpoints for sirolimus level draws, CBC, and metabolic panel orders; the lab result delivery pipeline; and the clinical alert generation service for out-of-range values. Check at 3-minute intervals during daytime hours. Alert after 10 minutes of sustained failure.
Presurgical Evaluation Portal
Monitor the presurgical evaluation portal login, MRI and PET image upload endpoints, sEEG scheduling pipeline, and surgical conference document submission service. Check at 3-minute intervals during business hours. Alert after 10 minutes of sustained failure.
Family Cascade Testing Portal
Monitor the cascade testing portal, genetic test order submission endpoints, variant report delivery service, and family counseling appointment scheduling system. Check at 5-minute intervals during business hours. Alert after 15 minutes of sustained failure.
GATOR1 Gene Panel Submission and Result Delivery
Monitor the genetic panel order routing endpoint, DEPDC5/NPRL2/NPRL3 panel result delivery API, and family trio testing coordination service. Check at 5-minute intervals during business hours. Alert after 15 minutes of sustained failure.
Multidisciplinary Care Coordination Portal
Monitor the care coordination portal login, care team messaging endpoints, medication change notification pipeline, and seizure log review interface. Check at 3-minute intervals. Alert after 10 minutes of sustained failure.
Patient and Family Portal
Monitor the patient-facing portal load endpoint, seizure diary review interface, and care plan document access service. Check at 5-minute intervals during daytime hours. Alert after 15 minutes of sustained failure.
Authentication Across All User Roles
Monitor authentication for epileptologists, neurosurgeons, geneticists, case managers, and families. Check at 1-minute intervals, 24/7. Authentication failures simultaneously lock out the entire clinical and family-facing platform.
SSL Certificates Across All Domains
Monitor SSL certificate expiry across the clinical portal, nocturnal monitoring API, presurgical evaluation portal, and family-facing domains. Alert 30 days in advance of expiry.
HIPAA and DEPDC5 Data Privacy Considerations
DEPDC5 care platforms handle PHI for patients with genetic epilepsy diagnoses, including germline variant data, seizure frequency records, presurgical evaluation study data (MRI, PET, sEEG), mTOR inhibitor therapy and blood level histories, and nocturnal monitoring sensor recordings. Genetic variant data identifying a DEPDC5 pathogenic variant has multigenerational implications: it establishes a hereditary epilepsy condition with direct consequences for life insurance, disability coverage, and family planning for all biological relatives.
Presurgical evaluation data — which includes stereo-EEG recordings and high-resolution neuroimaging — represents some of the most sensitive neurological PHI a platform may handle, and access controls, audit logging, and transmission security must meet HIPAA Security Rule standards. Nocturnal monitoring data streams from in-home sensors are PHI under HIPAA when linked to an identified patient and require business associate agreements with monitoring platform vendors. Uptime monitoring logs provide direct audit evidence of PHI availability technical safeguard compliance.
Alerting Strategy for DEPDC5 Focal Epilepsy Care Tech Platforms
Immediate 24/7 alert: Nocturnal monitoring sensor data ingestion and alert generation, authentication. Nocturnal seizures in DEPDC5 carry SUDEP risk; a monitoring pipeline failure is a patient safety event.
Sustained-failure alert (10 minutes) during daytime hours: mTOR inhibitor therapy scheduling and lab result delivery, presurgical evaluation portal, multidisciplinary care coordination portal — clinical workflows depend on platform availability during working hours.
Sustained-failure alert (15 minutes) during business hours: Seizure diary synchronization, family cascade testing portal, GATOR1 gene panel portal, patient and family portal.
30-day advance warning: SSL certificates across all domains.
Vigilmon's multi-region monitoring ensures nocturnal monitoring alert endpoints are verified from the cloud regions serving the sensor processing pipeline — critical for platforms where a single-region outage would silently disable caregiver alerting for nocturnal seizures.
Status Page for Epileptology Practice and Family Communication
A real-time status page gives epileptologists, neurosurgeons, and care coordinators immediate visibility into platform status when they arrive at clinic or prepare for a presurgical conference and find the evaluation portal or care coordination system unavailable. Rather than troubleshooting during a high-stakes multidisciplinary meeting, clinicians can confirm platform status in seconds and activate backup communication protocols.
For DEPDC5 families — who are managing drug-resistant epilepsy with SUDEP risk and complex presurgical evaluation timelines — a public status page prevents nocturnal monitoring system outages from being misinterpreted as sensor malfunction, and explains portal unavailability as a known platform issue rather than a user error. Include the status page URL in family onboarding materials and in the nocturnal monitoring setup documentation.
Vigilmon Setup for DEPDC5 Focal Epilepsy Care Tech Platforms
A practical starting configuration:
| Monitor | Check Interval | Alert Channel | |---------|----------------|---------------| | Nocturnal monitoring sensor pipeline and alert generation | 1 min | PagerDuty (24/7, immediate) | | Authentication / epileptology and family SSO | 1 min | Slack + PagerDuty (24/7) | | mTOR inhibitor therapy scheduling and lab delivery | 3 min | Slack (sustained 10 min, daytime) | | Presurgical evaluation portal | 3 min | Slack (sustained 10 min, business hours) | | Multidisciplinary care coordination portal | 3 min | Slack (sustained 10 min) | | Seizure diary submission and synchronization | 5 min | Slack (sustained 15 min) | | Family cascade testing portal | 5 min | Slack (sustained 15 min, business hours) | | GATOR1 gene panel submission and result delivery | 5 min | Slack (sustained 15 min, business hours) | | Patient and family portal | 5 min | Slack (sustained 15 min, daytime) | | SSL: all domains | Daily | Email (30-day warning) |
Getting started:
- Create a free account at vigilmon.online
- Add the nocturnal monitoring sensor data ingestion and alert generation endpoints as the highest-priority monitors with immediate 24/7 PagerDuty alerting
- Add authentication endpoints at 1-minute intervals with 24/7 alerting
- Configure mTOR inhibitor therapy scheduling and presurgical evaluation portal monitors with 10-minute sustained-failure alerting scoped to daytime and business hours
- Add seizure diary, family cascade testing, GATOR1 gene panel, and care coordination portal monitors
- Add the patient and family portal monitor
- Enable SSL certificate monitoring across all clinical, nocturnal monitoring, and family-facing domains
- Publish the status page URL in family onboarding materials and nocturnal monitoring setup documentation
Conclusion
DEPDC5-related focal epilepsy is one of the most common genetic causes of familial focal epilepsy, carrying drug resistance, elevated SUDEP risk, and the possibility of precision therapy with mTOR inhibitors and surgical resection for focal cortical dysplasia. The care technology platforms supporting DEPDC5 management — from nocturnal monitoring platforms protecting against SUDEP to presurgical evaluation portals coordinating sEEG and surgical conference to mTOR inhibitor monitoring systems tracking sirolimus levels — are the digital infrastructure on which both patient safety and treatment outcomes depend.
When nocturnal monitoring pipelines fail silently, when presurgical evaluation portals go down during a surgical conference preparation week, or when mTOR inhibitor scheduling systems are unavailable during drug level draw windows, the consequences are unmonitored nocturnal seizures, delayed surgical evaluation timelines, and inadequate pharmacological oversight of immunosuppressive therapy. Uptime monitoring gives DEPDC5 care tech teams the detection capability to catch failures within seconds, maintain the availability that drug-resistant focal epilepsy management demands, and demonstrate to families, hospital networks, and compliance reviewers that the platform is built for the stakes of GATOR1-pathway epilepsy care.
Start monitoring your DEPDC5 focal epilepsy care tech platform for free at vigilmon.online — HTTP/HTTPS monitoring, multi-region consensus alerting, SSL certificate monitoring, automatic status page, Slack and webhook alerts. No agent required. No credit card.
Tags: #monitoring #depdc5 #focalepilepsy #mtor #gator1 #focalcorticaldysplasia #ffevf #epilepticencephalopathy #sudep #epileptology #neurosurgery #digitalhealth #uptime #hipaa #seizure #presurgicalevaluation #sre